Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Renalytix Plc (RENX) Share News

IN BRIEF: Renalytix inks Texas contracts expanding insurance coverage

22nd Sep 2023 14:07

Renalytix PLC - London-based kidney health-focused diagnostics company - Says it has signed a contract with BlueCross and BlueShield of Texas to expand insurance coverage of KidneyIntelX in the state of Texas. Adds that it has executed a contract with Parkland Community Health Plan, a Dallas based insurance plan with over 300,000 covered lives and service in 7 counties, for insurance coverage of KidneyIntelX. Read More

TRADING UPDATES: Tintra receives bid approach; NCC trading in line

7th Sep 2023 20:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Renalytix hails KidneyIntelX inclusion in guidance to evaluate CKD

21st Aug 2023 10:16

(Alliance News) - Renalytix PLC on Monday said its laboratory developed test KidneyIntelX has been included in a draft guidance by Kidney Disease Improving Global Outcomes, a kidney disease-focused organisation. Read More

LONDON MARKET MIDDAY: UK retail sales fall; DWF agrees takeover

21st Jul 2023 11:45

(Alliance News) - Stock prices in London were mixed at midday on Friday, after a strong set of UK retail figures thanks to June's good weather was somewhat clouded by a fall in consumer confidence during the month of July. Read More

AIM WINNERS & LOSERS: Bowleven says fundraising efforts continue

21st Jul 2023 10:40

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

Renalytix & Vector Pharma sign Middle East distribution deal

21st Jul 2023 09:31

(Alliance News) - Renalytix PLC on Friday said it signed a deal with Vector Pharma FZCO for the distribution of its kidneyintelX.dkd testing in the Middle East. Read More

AIM WINNERS & LOSERS: Harvest Minerals slashes annual sales forecast

30th Jun 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

Renalytix shares soar on FDA testing platform approval

30th Jun 2023 10:20

(Alliance News) - Renalytix PLC on Friday said the US Food & Drug Administration has granted marketing authorisation for its KidneyIntelX.dkd prognostic testing platform. Read More

LONDON MARKET OPEN: Stocks rise amid strong US economic outlook

30th Jun 2023 09:22

(Alliance News) - European markets opened higher on Friday, shaking off weak economic data from China and instead taking heart from stronger economic growth from the US. Read More

Renalytix loss widens, revenue affected by disruption to testing

9th Jun 2023 14:30

(Alliance News) - Renalytix PLC on Friday said its net loss for the three months ended March 30 narrowed amid cuts in administrative costs. Read More

UK shareholder meetings calendar - next 7 days

1st Jun 2023 15:52

IN BRIEF: Renalytix picks Eversana to commercialise prognostic device

25th May 2023 12:14

Renalytix PLC - London-based kidney health-focused diagnostics company - Announces partnership with life-science commercialisation company Eversana Life Science Services LLC. Will expand commercial footprint for diabetic kidney disease prognostic device KidneyIntelX. Device aims to help clinicians better predict chronic kidney disease in adult type 2 diabetes patients. Companies will provide field deployment and training to primary care providers across key US regions this summer, complimenting Renalytix's existing sales efforts in major markets including New York. Renalytix says two large clinical utility studies have shown the product helps clinicians better understand risks to patients, resulting in improved medication use and faster specialist referrals. Expects additional data on the product's real-world utility to be released next month at the American Diabetes Association annual clinical meeting. Read More

TRADING UPDATES: Catenae hails court; Golden Metals likes copper find

22nd May 2023 16:10

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Renalytix says review results show utility of bioprognostic tool

19th Apr 2023 11:47

(Alliance News) - Renalytix PLC on Wednesday hailed the results of a new independent review, which it said demonstrated the utility of KidneyIntelX in diagnosing patients with kidney disease and diabetes. Read More

IN BRIEF: Renalytix to present data on efficacy of KidneyIntelX

12th Apr 2023 11:57

Renalytix PLC - London-based kidney health-focused diagnostics company - Says that two scientific presentations proving the utility of KidneyIntelX in minorities and veterans have been accepted at the upcoming National Kidney Foundation Spring Clinicals Conference taking place in Austin, Texas. Read More

EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs

30th Mar 2023 18:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Renalytix ups insurance coverage base in Northeast US via EmblemHealth

27th Mar 2023 12:04

(Alliance News) - Renalytix PLC on Monday said it expanded its insurance coverage base in the Northeast region of the US via a coverage contract with EmblemHealth, a non-profit health insurer with three million customers in the New York Tri-state area. Read More

FTSE 100 Latest

Value10,752.88

Change19.88